Skip to main content
. 2022 Jan 26;11:808300. doi: 10.3389/fonc.2021.808300

Figure 7.

Figure 7

A schematic diagram of the activation of NRF2 signaling and the development of CSC-like properties in CD133-enriched cancer cells. In colonospheres and the CD133-positive cell fraction, high CD133 levels induce PI3K/AKT activation and subsequently inactivate GSK-3β to stabilize NRF2 protein, which results in the acquisition of CSC-like properties, including anchorage-independent growth, sphere formation, facilitated migration, and resistance to anticancer drugs.